Target intelligence / Profile preview

Hepatitis C virus internal ribosome entry site RNA (HCV IRES)

Target
HCV IRES
Molecular classification
Other (structured viral RNA element), Translation regulatory RNA, Viral RNA element
01

Overview

The hepatitis C virus internal ribosome entry site RNA (HCV IRES) is a highly conserved, structured RNA region of approximately 340 nucleotides located within the 5′ untranslated region (UTR) of the HCV genome[1][2][6]. It mediates cap-independent initiation of protein translation by direct recruitment of the host cell's 40S ribosomal subunit, bypassing the need for many canonical eukaryotic initiation factors[5][6]. The HCV IRES forms several distinct secondary and tertiary structural domains that interact with both initiation factors and ribosomal subunits, enabling efficient translation of the viral polyprotein[2][3][5]. Because of its essential role in the viral life cycle and unique RNA-driven mechanism, the HCV IRES represents a validated antiviral target, and selective small molecules that bind specific IRES subdomains can inhibit viral translation and represent promising therapeutic strategies[4][5].

Other names
Hepatitis C virus IRESHCV IRESHCV internal ribosome entry siteHepatitis C virus 5'-untranslated regionHCV 5'-UTR
02

Mechanism of action

Inhibition of viral translation initiation by stabilizing non-productive conformations of the IRES RNA, thereby blocking ribosome recruitment and viral protein synthesis

03

Biological functions

Initiation of viral protein translationRibosome recruitmentCap-independent translation initiation
04

Disease associations

Infection (Hepatitis C virus infection)
05

Safety considerations

Targeting highly structured RNA elements may have off-target effects or result in viral resistance due to RNA sequence variabilityTherapeutic challenges include delivery, specificity, and potential for emergence of resistant viral strains
06

Interacting drugs

Benzimidazole translation inhibitors

1 more in the full profile.

Beyond the preview

Go deeper on Hepatitis C virus internal ribosome entry site RNA (HCV IRES).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus internal ribosome entry site RNA (HCV IRES).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call